Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) Myeloid
differential protein-2 (MD2) has been shown to play a critical role in the progression
Human mesenchymal stem cells (MSCs) are primary multipotent cells capable of
differentiatingLin, Jianjun,
Lin, Ke,
Huang, Lijiang,
Jiang, Yongsheng,
Ding, Xiaoxiao,
Luo, Wu,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Liang, Guang,
Qian, Jianchang,
Wang, Yi (2022) with TLR4 and its adaptor protein myeloid
differentiation protein 2 (MD2). Genetic loss of MD2 ameliorates
Talybov, Rustam,
Beylerli, Ozal,
Mochalov, Vadim,
Prokopenko, Alexey,
Ilyasova, Tatiana,
Trofimova, Tatiana,
Sufianov, Albert,
Guang, Yang (2022) in the
differential diagnosis of primary lymphomas of the central nervous system in comparison with highly malignant
Gareev, I,
Beylerli, O,
Wang, CL,
Sokhatskii, A,
Liang, YC,
Xiang, H,
Liu, CY,
Xu, X,
Guang, Y (2022) all biological processes, including cell proliferation, apoptosis, and cell
differentiation. Recent